MMS Holdings Expert Insights Blog
Experts at MMS share their insights on trending
topics in the pharmaceutical industry.
Leadership, Culture, and Success: A Conversation with Prasad M. Koppolu, COO of a Clinical Research Organization (CRO)
For its leadership and culture as a clinical research organization (CRO) in the pharmaceutical industry, MMS has received much recognition and praise recently. To uncover some of the reasons behind this success, we recently sat down with Prasad M. Koppolu, Chief...
Pro-Bono Ultra-rare Disease Regulatory Assistance Program Created By MMS for Patient Advocacy Groups
CANTON, Mich. (August 12, 2021) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced today the launch of its pro-bono support program aimed at advancing research for ultra-rare diseases. Within this program, MMS will select from patient advocacy...
Data CRO Expands its Virtual Learning Portfolio
Data CRO Expands its Virtual Learning Portfolio with New Life Sciences Courses in Inspection Readiness and Clinical Programming CANTON, Mich. (July 28, 2021) – MMS Holdings (MMS) – an award-winning, data-focused CRO – announced that its learning arm, MMS Academy, has...
MMS Poised for an Innovative Future with Best Clinical Research Organization Award and Two Key Executive Appointments
CANTON, Mich. (July 21, 2021) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO - announced the growth of its leadership team with the appointment of Kelly J. Hill to Executive Vice President (EVP) of Global Business Operations and Strategy and Michelle...
How to Maximize FSP Partnerships – Scalability, Innovation, and Efficiencies
FSP partnership models, when developed to find the right level of oversight, scale, pricing, and governance to meet a Sponsor’s needs, offer a functional provider solution that can benefit an organization in a rapidly evolving pharmaceutical industry. For example, The...
Attention Sponsors, Be Prepared to Publish Your Interim Clinical Study Results
Attention Sponsors, Be Prepared to Publish Your Interim Clinical Study Results Right now, imagining that Sponsors would be required to publish the results of their interim analysis before the end of the study seems impossible. However, this will eventually become an...
Whitepaper: CMC Regulatory Considerations for Successful Submission Planning
Combination Products: Understanding and Appreciation of CMC Regulatory Considerations for Successful Submission Planning Whitepaper [Fill out the form below to access the whitepaper] Combination products have emerged as powerful technologies for delivering...
Health Data Research UK Selects MMS as Data Services Partner for the International COVID-19 Data Alliance
LONDON (July 15, 2021) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced today that it has been selected by Health Data Research UK (HDR UK) – the national institute for health data science – as a partner to support the International COVID-19...
Navigating GxP Compliance with Remote Access
Over the past year, many professionals in clinical research have had to navigate through uncharted waters and adapt to remote auditing due to the COVID-19 pandemic. While the landscape of auditing has changed, the basics of confirming compliance remains the...